Treatment Regimens for Immunocompetent Elderly Patients with Primary Central Nervous System Lymphoma: A Scoping Review

SIMPLE SUMMARY: Most patients diagnosed with primary central nervous system lymphoma (PCNSL) are 60 years or older and tend to have a poor prognosis. Evidence to guide and optimize treatment choices for these vulnerable patients is limited. We performed a scoping review to identify and describe all...

Descripción completa

Detalles Bibliográficos
Autores principales: Schorb, Elisabeth, Isbell, Lisa Kristina, Illerhaus, Gerald, Ihorst, Gabriele, Meerpohl, Joerg J., Grummich, Kathrin, Nagavci, Blin, Schmucker, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428349/
https://www.ncbi.nlm.nih.gov/pubmed/34503078
http://dx.doi.org/10.3390/cancers13174268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428349/
https://www.ncbi.nlm.nih.gov/pubmed/34503078
http://dx.doi.org/10.3390/cancers13174268

Ejemplares similares